The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

About one third of lung transplant recipients have a genetic variant that makes them more likely to develop chronic lung ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

With the legislative session set to begin Monday, Jan. 12, Arizona lawmakers are preparing to take a hard look at the state’s ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

Heterogeneity of Debt Sources, Capital Allocation Efficiency, Enterprise Value, High-Quality Development Share and Cite: ...

In the heavy-duty truck segment, Fan said methanol-hydrogen trucks show several advantages over battery electric models: ...

A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...

Despite South Africa's record matric pass rate of 88% in 2025, the true state of the education system reveals a troubling ...

For generations, Brazilians have turned to a colorful garden plant to soothe aching joints, trusting experience long before ...

InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...